135 related articles for article (PubMed ID: 6692326)
1. Staging and treatment of clinically occult breast cancer.
Schwartz GF; Feig SA; Rosenberg AL; Patchefsky AS; Schwartz AB
Cancer; 1984 Mar; 53(6):1379-84. PubMed ID: 6692326
[TBL] [Abstract][Full Text] [Related]
2. Significance and staging of nonpalpable carcinomas of the breast.
Schwartz GF; Feig SA; Patchefsky AS
Surg Gynecol Obstet; 1988 Jan; 166(1):6-10. PubMed ID: 2827328
[TBL] [Abstract][Full Text] [Related]
3. Mammographically detected breast cancer. Nonpalpable is not a synonym for inconsequential.
Schwartz GF; Carter DL; Conant EF; Gannon FH; Finkel GC; Feig SA
Cancer; 1994 Mar; 73(6):1660-5. PubMed ID: 8156493
[TBL] [Abstract][Full Text] [Related]
4. Treatment and survival of female patients with nonpalpable breast carcinoma.
Tinnemans JG; Wobbes T; Holland R; Hendriks JH; Van der Sluis RF; De Boer HH
Ann Surg; 1989 Feb; 209(2):249-53. PubMed ID: 2537064
[TBL] [Abstract][Full Text] [Related]
5. [Axillary lymph node dissection in clinically occult breast cancer].
Le Bouëdec G; Pomel C; Chamussy E; Feillel V; de Latour M; Dauplat J
Bull Cancer; 1996 Jul; 83(7):581-8. PubMed ID: 8868947
[TBL] [Abstract][Full Text] [Related]
6. Clinically occult breast carcinoma: diagnostic approaches and role of axillary node dissection.
Meterissian S; Fornage BD; Singletary SE
Ann Surg Oncol; 1995 Jul; 2(4):314-8. PubMed ID: 7552620
[TBL] [Abstract][Full Text] [Related]
7. Nonpalpable breast cancer: needle-localized biopsy for diagnosis and considerations for treatment.
Marrujo G; Jolly PC; Hall MH
Am J Surg; 1986 May; 151(5):599-602. PubMed ID: 3010754
[TBL] [Abstract][Full Text] [Related]
8. Pathologic findings in nonpalpable invasive breast cancer.
McKinney CD; Frierson HF; Fechner RE; Wilhelm MC; Edge SB
Am J Surg Pathol; 1992 Jan; 16(1):33-6. PubMed ID: 1309412
[TBL] [Abstract][Full Text] [Related]
9. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G
Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108
[TBL] [Abstract][Full Text] [Related]
10. Axillary node status in nonpalpable breast cancer.
Dowlatshahi K; Snider HC; Kim R
Ann Surg Oncol; 1995 Sep; 2(5):424-8. PubMed ID: 7496837
[TBL] [Abstract][Full Text] [Related]
11. Occult lesions of the breast.
Poole GV; Choplin RH; Sterchi JM; Leinbach LB; Myers RT
Surg Gynecol Obstet; 1986 Aug; 163(2):107-10. PubMed ID: 3016925
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of the results of 137 subclinical breast lesions excisions. Value of ultrasonography in the early diagnosis of breast cancer].
Jacob D; Brombart JC; Muller C; Lefèbvre C; Massa F; Depoerck A
J Gynecol Obstet Biol Reprod (Paris); 1997; 26(1):27-31. PubMed ID: 9091540
[TBL] [Abstract][Full Text] [Related]
13. Clinically occult breast cancer. Multicentricity and implications for treatment.
Schwartz GF; Patchefsky AS; Feig SA; Shaber GS; Schwartz AB
Ann Surg; 1980 Jan; 191(1):8-12. PubMed ID: 6243455
[TBL] [Abstract][Full Text] [Related]
14. The case for the omission of axillary staging in invasive breast carcinoma that exhibits a predominant tubular growth pattern on preoperative biopsy.
Ramzi S; Hyett EL; Wheal AS; Cant PJ
Breast J; 2018 Jul; 24(4):493-500. PubMed ID: 29476580
[TBL] [Abstract][Full Text] [Related]
15. The anatomy of missed breast cancers.
Reintgen D; Berman C; Cox C; Baekey P; Nicosia S; Greenberg H; Bush C; Lyman GH; Clark RA
Surg Oncol; 1993; 2(1):65-75. PubMed ID: 8252194
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic correlations and significance of clinically occult mammary lesions.
Schwartz GF; Feig SA; Patchefsky AS
Cancer; 1978 Mar; 41(3):1147-53. PubMed ID: 638959
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
[TBL] [Abstract][Full Text] [Related]
18. The pathology of nonpalpable breast cancer.
Kopald KH; Hiatt JR; Irving C; Giuliano AE
Am Surg; 1990 Dec; 56(12):782-7. PubMed ID: 2268107
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
20. Axillary node metastasis from T1N0M0 breast cancer: possible avoidance of dissection in a subgroup.
Iwasaki Y; Fukutomi T; Akashi-Tanaka S; Nanasawa T; Tsuda H
Jpn J Clin Oncol; 1998 Oct; 28(10):601-3. PubMed ID: 9839499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
